A Phase II, Single-Arm Study of De-Escalation and Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line Therapy Followed By a Second Attempt after Nilotinib and Asciminib Combination: Dante Study / Rosti, Gianantonio; Saglio, Giuseppe; Stagno, Fabio; Valsecchi, Diletta; Nardozza, Aurelio Pio; Coco, Paola; Breccia, Massimo; Iurlo, Alessandra. - In: BLOOD. - ISSN 0006-4971. - 140:1(2022), pp. 9643-9644. [10.1182/blood-2022-157002]
A Phase II, Single-Arm Study of De-Escalation and Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line Therapy Followed By a Second Attempt after Nilotinib and Asciminib Combination: Dante Study
Breccia, Massimo;
2022
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
